FDA Approved: ZYNLONTA — Supplemental Application (ADC Therapeutics America, Inc.)

View source ↗

Summary

FDA overview of a supplemental application for ZYNLONTA (loncastuximab tesirine) by ADC Therapeutics America, Inc., indicating an additional regulatory submissi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Zynlonta (loncastuximab tesirine)

Snippet

SUPPL AP for ZYNLONTA (LONCASTUXIMAB TESIRINE)